⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001758838

Partridge Andrew John

Reports to the SEC for 2 companies · SUNNYVALE, CA

Transactions

10

Companies

2

Filings

6

CIK

0001758838

Forms 4 and 5

Insider transactions

10 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	GRALGRAIL, Inc.S Sale	Chief Growth Officer	SSale	−7,873 sh	$146.39	−$1.15M	155,865
2026-06-04	GRALGRAIL, Inc.S Sale	Chief Growth Officer	SSale	−1,491 sh	$61.08	−$91.1K	163,738
2022-02-09	Turning Point Therapeutics, Inc.A Award	EVP & Chief Commercial Officer	AAward	+16.3K sh	—	—	38,361
2022-02-09	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & Chief Commercial Officer	AAward	+58.6K sh	—	—	58,600
2022-02-09	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−221 sh	$36.30	−$8,022.3	22,078
2021-07-14	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−1,869 sh	$74.90	−$140K	21,767
2021-02-08	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & Chief Commercial Officer	AAward	+9,733 sh	—	—	9,733
2021-02-08	Turning Point Therapeutics, Inc.A Award	EVP & Chief Commercial Officer	AAward	+2,136 sh	—	—	23,636
2020-07-13	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & Chief Commercial Officer	AAward	+128K sh	—	—	127,500
2020-07-13	Turning Point Therapeutics, Inc.A Award	EVP & Chief Commercial Officer	AAward	+21.5K sh	—	—	21,500

Recent filings

6

Accepted (ET)
Oct 74
Partridge Andrew John0001628280-26-065365
SEC(opens sec.gov)
Jun 54
Partridge Andrew John0001628280-26-041356
SEC(opens sec.gov)
Feb 114
Partridge Andrew John0001209191-22-008983
SEC(opens sec.gov)
Jul 154
Partridge Andrew John0001209191-21-046809
SEC(opens sec.gov)
Feb 104
Partridge Andrew John0001209191-21-009371
SEC(opens sec.gov)
Jul 144
Partridge Andrew John0001209191-20-042407
SEC(opens sec.gov)

Companies

2

Address

C/O GRAIL, INC. 250 S. MATHILDA AVE. SUITE 100

SUNNYVALE, CA, 94086